Particulars (Rupees in Crores.) | Jun-2025 | Mar-2025 | Dec-2024 | Sept-2024 | Jun-2024 |
---|---|---|---|---|---|
Gross Sales | 1,569.57 | 1,720.3 | 1,415.05 | 1,223.7 | 1,194.91 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,569.57 | 1,720.3 | 1,415.05 | 1,223.7 | 1,194.91 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 10.43 | 58.57 | 9.42 | 4.6 | 2.51 |
Total Income | 1,580 | 1,778.87 | 1,424.47 | 1,228.3 | 1,197.42 |
Total Expenditure | 1,187.44 | 1,299.7 | 1,129.9 | 1,045.37 | 1,023.71 |
PBIDT | 392.56 | 479.17 | 294.57 | 182.93 | 173.71 |
Interest | 51.5 | 56.4 | 57.8 | 52.61 | 49.19 |
PBDT | 341.06 | 422.77 | 236.77 | 130.32 | 124.52 |
Depreciation | 116.84 | 110.43 | 106.09 | 107.51 | 106.06 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 60.02 | 80.34 | 34.97 | 23.18 | 18.41 |
Deferred Tax | 3.12 | -1.87 | 5.1 | -18.09 | -12.16 |
Reported Profit After Tax | 161.08 | 233.87 | 90.61 | 17.72 | 12.21 |
Minority Interest After NP | -1.34 | -0.9 | 0.64 | 0.11 | 0.17 |
Net Profit after Minority Interest | 163.02 | 233.67 | 92.3 | 19.84 | 12.51 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 163.02 | 233.67 | 92.3 | 19.84 | 12.51 |
EPS (Unit Curr.) | 3.02 | 4.34 | 1.71 | 0.37 | 0.23 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 20 | 0 |
Equity | 107.96 | 107.85 | 107.85 | 107.83 | 107.83 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 25.01 | 27.85 | 20.81 | 14.94 | 14.53 |
PBDTM(%) | 21.72 | 24.57 | 16.73 | 10.64 | 10.42 |
PATM(%) | 10.26 | 13.59 | 6.4 | 1.44 | 1.02 |
Finished Dosage Formulations (FDF) business also saw a 27% growth, while the Generics business saw moderate growth of 5%
The said transaction falls under related party transactions. However, the same is being carried at arm’s length price.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.